Order Article Reprints
Journal: Medicina, 2023
Volume: 59
Number: 178
Article:
A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy
Authors:
by
Seunghoon Yoo, Dae Hyuk You, Jeongyoon Lee, H. Christian Hong and Sung Jin Lee
Link:
https://www.mdpi.com/1648-9144/59/1/178
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.